欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号DE/H/7001/004
药品名称Tapentadol AL 150 mg Retardtabletten
活性成分
    • Tapentadol Phosphate 150.0 mg
剂型Prolonged-release tablet
上市许可持有人ALIUD PHARMA GmbH Gottlieb-Daimler-Str. 19 89150 Laichingen Germany
参考成员国 - 产品名称Germany (DE)
Tapentadol Develco 150 mg Retardtabletten
互认成员国 - 产品名称
    • Poland (PL)
      BINATTA
    • Czechia (CZ)
      Tapentadol phosphate prolonged-release tablets
    • Slovakia (SK)
    • Croatia (HR)
    • Denmark (DK)
    • Netherlands (NL)
      Tapentadol Develco 150 mg, tabletten met verlengde afgifte
    • Iceland (IS)
    • Spain (ES)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
许可日期2022/09/01
最近更新日期2024/09/13
药物ATC编码
    • N02AX06 tapentadol
申请类型
  • TypeLevel1：Known Active Substance
  • TypeLevel2：Initial Application
  • TypeLevel3：Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4：Chemical Substance
  • TypeLevel5：Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase